No Data
No Data
No Data
No Data
No Data
VYNE Therapeutics (NASDAQ:VYNE) Is In A Good Position To Deliver On Growth Plans
Yahoo FinanceApr 13 08:08 ET
12 Health Care Stocks Moving In Friday's After-Market Session
GainersQilian Intl Hldg Gr (NASDAQ:QLI) shares rose 63.8% to $1.04 during Friday's after-market session. The market value of their outstanding shares is at $37.1 million. Sunshine Biopharma (NASDAQ:SB
BenzingaMar 29 16:30 ET
VYNE Therapeutics to Participate in the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference
BRIDGEWATER, N.J., March 19, 2024 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) ("VYNE" or the "Company"), a clinical-stage biopharmaceutical company focused on developing proprietary, i
GlobeNewswireMar 19 08:00 ET
VYNE Therapeutics Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
Yahoo FinanceMar 3 07:03 ET
Vyne Therapeutics Inc's New Natural and Human Disruptions Risk – A Cause for Worry?
TipRanksMar 3 01:01 ET
Vyne Therapeutics Files for $250M Mixed Shelf
Seeking AlphaMar 1 17:40 ET
No Data
No Data
Benhardman :